Advanced Search

Technical Analysis for VINC - Vincera Pharma, Inc.

Grade Last Price % Change Price Change
F 17.53 -0.40% -0.07
VINC closed down 3.83 percent on Friday, April 16, 2021, on 64 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical VINC trend table...
Date Alert Name Type % Chg
Stochastic Reached Oversold Weakness -0.40%
Wide Bands Range Expansion -0.40%
Oversold Stochastic Weakness -0.40%
Wide Bands Range Expansion -4.21%
Oversold Stochastic Weakness -4.21%
Shooting Star Candlestick Bearish -7.98%
Doji - Bearish? Reversal -7.98%
Wide Bands Range Expansion -7.98%
Oversold Stochastic Weakness -7.98%
Wide Bands Range Expansion -7.40%
Older End-of-Day Signals for VINC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown 37 minutes ago
Down 2 % 37 minutes ago
Down 1% 37 minutes ago
Fell Below Previous Day's Low 37 minutes ago
Up 2% about 1 hour ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Vincera Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in clinical trials. Its drug candidates are in development for the treatment of solid tumors, leukemia, B-cell malignancies, lymphomas, and myelodysplastic syndrome. Vincera Pharma, Inc. is based in Santa Clara, California.
Classification
Sector: Financial Services
Industry: Shell Companies
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Solid Tumors Treatment Of Cancer Lymphoma Hematology Leukemia Myelodysplastic Syndrome Anatomical Pathology Treatment Of Solid Tumors

Is VINC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Apr 10 Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021
Apr 7 Vincerx Pharma To Host Key Opinion Leader Webinar on Bioconjugation and CDK9 Inhibitors for the Treatment of Hematologic and Solid Tumors
Apr 5 Vincerx Pharma Announces Redemption of Public Warrants
Apr 1 Vincerx Pharma Announces Formation of Scientific Advisory Board to Advance its Clinical Pipeline
Mar 30 What Kind Of Investors Own Most Of Vincerx Pharma, Inc. (NASDAQ:VINC)?
Mar 23 Vincerx Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update
Mar 10 Vincerx Pharma Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021
Mar 2 Vincerx Pharma Strengthens Management Team with Three New Appointments
Feb 24 Vincerx Pharma To Host Key Opinion Leader Webinar on VIP152 for the Treatment of Hematologic and Solid Tumors
Feb 17 Vincerx Pharma to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
See more VINC news...

Indicators

Indicator Value
52 Week High 26.75
52 Week Low 0.0
Average Volume 107,116
200-Day Moving Average 0.00
50-Day Moving Average 19.79
20-Day Moving Average 19.53
10-Day Moving Average 18.78
Average True Range 1.34
ADX 11.81
+DI 17.29
-DI 22.28
Chandelier Exit (Long, 3 ATRs ) 22.74
Chandelier Exit (Short, 3 ATRs ) 21.51
Upper Bollinger Band 22.57
Lower Bollinger Band 16.48
Percent B (%b) 0.18
BandWidth 31.20
MACD Line -0.62
MACD Signal Line -0.43
MACD Histogram -0.1872
Fundamentals Value
Market Cap 246.13 Million
Num Shares 14 Million
EPS
Price-to-Sales 0.00
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.10
Resistance 3 (R3) 19.23 18.87 18.85
Resistance 2 (R2) 18.87 18.48 18.80 18.77
Resistance 1 (R1) 18.23 18.25 18.05 18.10 18.68
Pivot Point 17.87 17.87 17.78 17.80 17.87
Support 1 (S1) 17.23 17.48 17.05 17.10 16.52
Support 2 (S2) 16.87 17.25 16.80 16.43
Support 3 (S3) 16.23 16.87 16.35
Support 4 (S4) 16.10